Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9311700 | Urology | 2005 | 4 Pages |
Abstract
Atorvastatin exhibits significant antiproliferative and pro-apoptotic activity in human bladder cancer cells. This, coupled with its established clinical safety profile, provides a rationale for its use as a potential chemopreventive agent against bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ashish M. Kamat, Gina M. Nelkin,